Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Ultragenyx: Q4 Earnings Snapshot
Ultragenyx: Q4 Earnings Snapshot
Associated Press Finance
Fri, February 13, 2026 at 6:18 AM GMT+9 1 min read
In this article:
RARE
-1.59%
NOVATO, Calif. (AP) — NOVATO, Calif. (AP) — Ultragenyx Pharmaceutical Inc. (RARE) on Thursday reported a loss of $129 million in its fourth quarter.
The Novato, California-based company said it had a loss of $1.29 per share.
The results fell short of Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of $1.20 per share.
The biotechnology company posted revenue of $207 million in the period, topping Street forecasts. Seven analysts surveyed by Zacks expected $202.9 million.
For the year, the company reported a loss of $575 million, or $5.83 per share. Revenue was reported as $673 million.
This story was generated by Automated Insights () using data from Zacks Investment Research. Access a Zacks stock report on RARE at
Terms and Privacy Policy
Privacy Dashboard
More Info